期刊文献+

侧脑室注射orexin B对MPTP帕金森病模型小鼠运动行为影响

EFFECT OF INTRACEREBROVENTRICULAR INJECTION OF OREXIN B ON MOTOR BEHAVIOR IN A MOUSE MODEL OF PARKINSON’S DISEASE INDUCED BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
下载PDF
导出
摘要 目的探究侧脑室注射orexin B对1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)帕金森病模型小鼠运动行为的影响。方法将小鼠随机分为正常对照组、MPTP组、orexin B组和orexin B+MPTP组。采用转棒实验观察各组小鼠在旋转棒上停留的时间。结果与正常对照组相比,MPTP组小鼠在旋转棒上停留的时间显著缩短(t=6.83,P<0.01);侧脑室注射orexin B的正常小鼠在旋转棒上停留的时间与正常对照组相比差异无显著性(P>0.05),然而,侧脑室注射orexin B的MPTP模型小鼠在旋转棒上停留的时间较MPTP组明显延长(t=3.17,P<0.05)。结论侧脑室注射orexin B可改善MPTP诱导的小鼠运动障碍。 Objective To investigate the effect of intracerebroventricular injection of orexin B on motor behavior in a mouse model of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP).Methods Mice were randomly divided into normal control group,MPTP group,orexin B group,and orexin B+MPTP group.The rotarod test was used to observe the retention time of mice on the rotarod.Results Compared with the normal control group,the MPTP group had a significant reduction in the retention time on the rotarod(t=6.83,P<0.01).There was no significant difference in retention time on the rotarod between the normal mice with intracerebroventricular injection of orexin B and the mice in the normal control group(P>0.05).Compared with the MPTP group,the orexin B+MPTP group had a significant increase in the retention time on the rotarod(t=3.17,P<0.05).Conclusion Intracerebroventricular injection of orexin B can improve dyskinesia induced by MPTP in mice.
作者 卞康 薛雁 陈蕾 BIAN Kang;XUE Yan;CHEN Lei(Department of Physiology and Pathophysiology,School of Basic Medicine,Qingdao University Medical College,Qingdao 266071,China)
出处 《青岛大学学报(医学版)》 CAS 2021年第2期186-189,共4页 Journal of Qingdao University(Medical Sciences)
基金 国家自然科学基金项目(31671076)。
关键词 食欲素 输注 脑室内 帕金森病 旋转棒性能试验 动作障碍 小鼠 orexins infusions,intraventricular Parkinson disease rotarod performance test movement disorders mice
  • 相关文献

参考文献3

二级参考文献23

  • 1Asai H, Hirano M, Furiya Y, Udaka F, Morikawa M, Kanbayashi T, et al. Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease. Clin Neurol Neurosurg 2009, 111: 341-344.
  • 2Poceta JS, Parsons L, Engelland S, Kripke DF. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease. Sleep Med 2009, 10: 129-133.
  • 3Mandel RJ, Spratt SK, Snyder RO, Left SE. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line- derived neurotrophic factor protects nigral neurons in a progres- sive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci U S A 1997, 94: 14083-14088.
  • 4Chen CT, Dun SL, Kwok EH, Dun NJ, Chang JK. Orexin A-like immunoreactivity in the rat brain. Neurosci Lett 1999, 260: 161-164.
  • 5Marinova-Mutafchieva L, Sadeghian M, Broom L, Davis JB, Medhurst AD, Dexter DT. Relationship between microglial acti- vation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. J Neurochem 2009, 110: 966-975.
  • 6Gerashchenko D, Murillo-Rodriguez E, Lin L, Xu M, Hallett L, Nishino S, et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 2003, 184: 1010-1016.
  • 7Jeon BS, Jackson-Lewis V, Burke RE. 6-Hydroxydopamine le- sion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration 1995, 4:131-137.
  • 8Fronczek R, Baurnann CR, Lammers GJ, Bassetti CL, Overeem S. Hypocretin/orexin disturbances in neurological disorders. Sleep Med Rev 2009, 13: 9-22.
  • 9Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98: 365-376.
  • 10Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98: 437-451.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部